CO [China Cord Blood] SC TO-I/A: (Original Filing)

[_____________ SCHEDULE TO (Amendment No. 2) _____________ (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) _____________ CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 _____________________ ) _____________ Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong] [HONG KONG, China, December 13, - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “We believe shareholders will appreciate our simplified capital structure. With no further dilution, shareholders will fully enjoy the benefits of our operational accomplishments and robust growth, even on a per share basis. With all the stakeholders’ interests now]

By | 2016-02-29T15:45:48+00:00 December 13th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC TO-I/A: _____________ SCHEDULE TO (Amendment No. 2) _____________ (Rule

[_____________ SCHEDULE TO (Amendment No. 2) _____________ (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) _____________ CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 _____________________ ) _____________ Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong] [HONG KONG, China, December 13, - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “We believe shareholders will appreciate our simplified capital structure. With no further dilution, shareholders will fully enjoy the benefits of our operational accomplishments and robust growth, even on a per share basis. With all the stakeholders’ interests now]

By | 2016-02-29T15:47:01+00:00 December 13th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] SC TO-I/A: _____________HEDULE TO (Amendment No. 2) _____________ (Rule 14d-100)

[_____________HEDULE TO (Amendment No. 2) _____________ (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) _____________ CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 _____________________ ) _____________bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower] [HONG KONG, China, December 13, - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, We believe shareholders will appreciate our simplifiedpital structure.With no further dilution, shareholders will fully enjoy the benefits of our operational accomplishments and robust growth, even on a per share basis.Withl the stakeholders interests now fullyigned, we willntinue to]

By | 2016-02-04T18:02:43+00:00 December 13th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] 8-K: China Automotive Systems Appoints PricewaterhouseCoopers Zhong Tian CPAs

[China Automotive Systems Appoints PricewaterhouseCoopers Zhong Tian CPAs Limited Company as Auditors WUHAN, Hubei, China, December 13, 2010 — China Automotive Systems, Inc. (NASDAQ: CAAS) Schwartz Levitsky Feldman LLP , who resigned Schwartz Levitsky Feldman LLP The appointment of PricewaterhouseCoopers Zhong Tian CPAs About China Automotive Systems, Inc. http://www.caasauto.com Based in Hubei Province, People's Republic of China, China Automotive Systems,] [Form 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 13, 2010 (December 8, 2010) China Automotive Systems, Inc. Delaware 000-33123 33-0885775 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 1 Henglong Road, Yu Qiao Development Zone Shashi District, Jing Zhou City Hubei Province People’s Republic of China (86) 27-5981 8527 ¨]

By | 2016-03-28T17:57:07+00:00 December 13th, 2010|Categories: CAAS, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

OSN [Ossen Innovation] F-1/A: Amendment No. 7 to FORM F-1 REGISTRATION STATEMENT

[Amendment No. 7 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OSSEN INNOVATION CO., LTD. British Virgin Islands 3312 Not Applicable (State or other jurisdiction of incorporation or organization) (Primary standard industrial classification code number) (I.R.S. Employer Identification Number) 518 Shangcheng Road, Floor 17, Shanghai, 200120, People’s Republic of China +86 (21) 6888-8886 CT Corporation System 111] [INDEPENDENT REGISTERED ACCOUNTING FIRM CONSENT We consent to the use of this Registration Statement on Form F-1, amendment No. 7, for Ossen Innovation Co., Ltd. of our report dated July 7, 2010, relating to the consolidated balance sheets of Ossen Innovation Co., Ltd. and Subsidiaries as of December 31, 2009 and 2008 and the related consolidated statements of operations, shareholders’]

IDI [IDI] 6-K: (Original Filing)

[FORM 6-K December 9, 2010 SearchMedia Holdings Limited ——————————————————————————————————— Cayman Islands ——————————————————————————————————— (Jurisdiction of incorporation or organization) 15A Zhao Feng Universe Building ——————————————————————————————————— x x n/a SearchMedia Holdings Limited Paul Conway Paul Conway Chief Executive Officer 6-K 1 htm_5487.htm LIVE FILING]

By | 2016-03-19T16:37:20+00:00 December 13th, 2010|Categories: Chinese Stocks, IDI, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar